Loading data for TGTX — first visit, this takes a few seconds.
TG Therapeutics, Inc. (TGTX)
NasdaqCM: TGTX
· Real-Time Price · USD
55.98
-0.73 (-1.29%)
At close: Sep 04, 2026, 8:00 PM
56.40
+0.74%
After-hours: 7:40 PM
The price, the headline numbers and the latest news, in one place.
TG Therapeutics, Inc. (TGTX) Stock Price, Analysis & Data
No data available
| Bid | 48.41 |
| Market Cap | 8.57B |
| Revenue (ttm) | 800M |
| Net Income (ttm) | 441M |
| 1.66 | |
| 2.74 | |
| 20.43 | |
| 18.88 | |
| P/B (ttm) | 13.61 |
| P/S (ttm) | 10.72 |
| Earnings Date | Nov 2, 2026 |
| Ask | 64.12 |
| Volume | 991,888 |
| Avg. Volume (20D) | 2,465,591 |
| Open | 56.33 |
| Previous Close | 56.71 |
| Day's Range | 55.56 - 56.70 |
| 52-Week Range | 26.76 - 59.30 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TGTX
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and activ...
Industry Biotechnology
Sector Healthcare
IPO Date May 3, 2010
Employees 399
Stock Exchange NasdaqCM
Ticker Symbol TGTX
Website https://www.tgtherapeutics.com
Financial Performance
In 2025, TG Therapeutics's revenue was 616.29M, an increase of 87.32% compared to the previous year's 329M. Earnings were 447.18M, an increase of 1,812.41%.
Financial StatementsEarnings Surprise
TG Therapeutics has released their quarterly earnings on Aug 3, 2026:
- Revenue of $240.34M misses estimates by $0, with 70.27% YoY growth.
- EPS of 0.05 misses estimates by -0.39, with -70.59% YoY decline.
TG Therapeutics, Inc. is scheduled to release its earnings on Nov 2, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade



